A crisis in clinical research

被引：0

作者：

Hong, David S. ^{[1
]}

LoRusso, Patricia ^{[2
]}

Sznol, Mario ^{[2
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Div Invest Canc Therapeut, Houston, TX 77030 USA

[2] Yale Sch Med, New Haven, CT USA

来源：

JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2024年 / 12卷 / 07期

关键词：

clinical trials as topic; immunotherapy; clinical trials; phase II as topic; phase III as topic;

D O I：

10.1136/jitc-2023-008520

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The clinical research pipeline is critical to ensuring continued development of novel treatments that can offer patients with cancer safe and effective options. Unfortunately, progress has slowed since the COVID-19 pandemic due to uncovered, systemic inefficiencies across critical processes. Towards initiating discussion on how to reinvigorate clinical research, the Society for Immunotherapy of Cancer (SITC) hosted a virtual summit that characterized issues and formed potential solutions. This commentary serves to highlight the crisis facing clinical research as well as stimulate field-wide discussion on how to better serve patients into the future.

引用

页码：1 / 4

页数：4

共 50 条

[31] Tutorials in clinical research: Part III. Selecting a research approach to best answer a clinical question
Neely, JG
Hartman, JM
Wallace, MS
Forsen, JW
LARYNGOSCOPE, 2001, 111 (05) : 821 - 830
[32] The Role of the Data and Safety Monitoring Board in a Clinical Trial: The CRISIS Study
Holubkov, Richard
Casper, T. Charles
Dean, J. Michael
Anand, K. J. S.
Zimmerman, Jerry
Meert, Kathleen L.
Newth, Christopher J. L.
Berger, John
Harrison, Rick
Willson, Douglas F.
Nicholson, Carol
PEDIATRIC CRITICAL CARE MEDICINE, 2013, 14 (04) : 374 - 383
[33] The role and potential contribution of clinical research nurses to clinical trials
Spilsbury, Karen
Petherick, Emily
Cullum, Nicky
Nelson, Andrea
Nixon, Jane
Mason, Su
JOURNAL OF CLINICAL NURSING, 2008, 17 (04) : 549 - 557
[34] Influence of Clinical Research Investigator Fraud on Clinical Trial Participation
Purnachandra Garimella
Irwin G. Martin
Therapeutic Innovation & Regulatory Science, 2013, 47 : 90 - 94
[35] Adaptations to clinical trials in health research: a guide for clinical researchers
Holliday, Elizabeth G.
Weaver, Natasha
Barker, Daniel
Oldmeadow, Christopher
MEDICAL JOURNAL OF AUSTRALIA, 2023, 218 (10) : 451 - 454
[36] Statistical controversies in clinical research: early-phase adaptive design for combination immunotherapies
Wages, N. A.
Slingluff, C. L., Jr.
Petroni, G. R.
ANNALS OF ONCOLOGY, 2017, 28 (04) : 696 - 701
[37] Recent research and clinical progress of CTLA-4-based immunotherapy for breast cancer
Zhang, Hongsheng
Mi, Jintao
Xin, Qi
Cao, Weiwei
Song, Chunjiao
Zhang, Naidan
Yuan, Chengliang
FRONTIERS IN ONCOLOGY, 2023, 13
[38] Influence of Clinical Research Investigator Fraud on Clinical Trial Participation
Garimella, Purnachandra
Martin, Irwin G.
THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2013, 47 (01) : 90 - 94
[39] Global Alzheimer Research Summit Basic and clinical research Present and future Alzheimer research
Gonsalves, Danielle
Jovanovic, Katarina
Dias, Bianca Da Costa
Weiss, Stefan F. T.
PRION, 2012, 6 (01) : 7 - 10
[40] Clinical research monitoring: scenarios and challenges
Sierra Romero, Gustavo Adolfo
REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL, 2013, 46 (01) : 3 - 6

← 1 2 3 4 5 →